Atossa Therapeutics, INC. (ATOS) SEC Filings — 2026
2 SEC filings for Atossa Therapeutics, INC. (ATOS) in 2026.
Filings
- Atossa's (Z)-Endoxifen Shows Promise in Breast Cancer Trials — 10-K · Mar 25, 2026
- ATOSSA THERAPEUTICS Files 8-K with Financial Statements — 8-K · Mar 25, 2026